Literature DB >> 33414401

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.

Antonella Padella1, Maria Chiara Fontana2, Giovanni Marconi3,4, Eugenio Fonzi2, Elisabetta Petracci2, Anna Ferrari2, Carmen Baldazzi3,4, Cristina Papayannidis3,4, Andrea Ghelli Luserna Di Rorá2, Nicoletta Testoni3,4, Gastone Castellani3,4, Torsten Haferlach5, Giovanni Martinelli6, Giorgia Simonetti2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33414401      PMCID: PMC7791026          DOI: 10.1038/s41408-020-00396-x

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN: 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  14 in total

1.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

2.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

3.  Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.

Authors:  Niki Karachaliou; Jillian Wilhelmina Paulina Bracht; Manuel Fernandez Bruno; Ana Drozdowskyj; Ana Gimenez Capitan; Teresa Moran; Enric Carcereny; Manuel Cobo; Manuel Domine; Imane Chaib; Jose Luis Ramirez; Carlos Camps; Mariano Provencio; Alain Vergnenegre; Guillermo Lopez-Vivanco; Margarita Majem; Bartomeu Massuti; Rafael Rosell
Journal:  J Thorac Oncol       Date:  2018-11-22       Impact factor: 15.609

Review 4.  The Tumor Suppressor PALB2: Inside Out.

Authors:  Mandy Ducy; Laura Sesma-Sanz; Laure Guitton-Sert; Anahita Lashgari; Yuandi Gao; Nadine Brahiti; Amélie Rodrigue; Guillaume Margaillan; Marie-Christine Caron; Jacques Côté; Jacques Simard; Jean-Yves Masson
Journal:  Trends Biochem Sci       Date:  2019-01-10       Impact factor: 13.807

5.  Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Authors:  Maria C Villarroel; N V Rajeshkumar; Ignacio Garrido-Laguna; Ana De Jesus-Acosta; Siân Jones; Anirban Maitra; Ralph H Hruban; James R Eshleman; Alison Klein; Daniel Laheru; Ross Donehower; Manuel Hidalgo
Journal:  Mol Cancer Ther       Date:  2010-12-06       Impact factor: 6.261

6.  Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Authors:  Margaret Nieborowska-Skorska; Elisabeth M Paietta; Ross L Levine; Hugo F Fernandez; Martin S Tallman; Mark R Litzow; Tomasz Skorski
Journal:  Blood Adv       Date:  2019-12-10

7.  Heterozygous mutations in PALB2 cause DNA replication and damage response defects.

Authors:  Jenni Nikkilä; Ann Christin Parplys; Katri Pylkäs; Muthiah Bose; Yanying Huo; Kerstin Borgmann; Katrin Rapakko; Pentti Nieminen; Bing Xia; Helmut Pospiech; Robert Winqvist
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Homologous recombination DNA repair defects in PALB2-associated breast cancers.

Authors:  Anqi Li; Felipe C Geyer; Pedro Blecua; Ju Youn Lee; Pier Selenica; David N Brown; Fresia Pareja; Simon S K Lee; Rahul Kumar; Barbara Rivera; Rui Bi; Salvatore Piscuoglio; Hannah Y Wen; John R Lozada; Rodrigo Gularte-Mérida; Luca Cavallone; Zoulikha Rezoug; Tu Nguyen-Dumont; Paolo Peterlongo; Carlo Tondini; Thorkild Terkelsen; Karina Rønlund; Susanne E Boonen; Arto Mannerma; Robert Winqvist; Marketa Janatova; Pathmanathan Rajadurai; Bing Xia; Larry Norton; Mark E Robson; Pei-Sze Ng; Lai-Meng Looi; Melissa C Southey; Britta Weigelt; Teo Soo-Hwang; Marc Tischkowitz; William D Foulkes; Jorge S Reis-Filho
Journal:  NPJ Breast Cancer       Date:  2019-08-08

Review 9.  The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.

Authors:  Thales C Nepomuceno; Giuliana De Gregoriis; Francisco M Bastos de Oliveira; Guilherme Suarez-Kurtz; Alvaro N Monteiro; Marcelo A Carvalho
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

10.  Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.

Authors:  Giorgia Simonetti; Antonella Padella; Italo Farìa do Valle; Maria Chiara Fontana; Eugenio Fonzi; Samantha Bruno; Carmen Baldazzi; Viviana Guadagnuolo; Marco Manfrini; Anna Ferrari; Stefania Paolini; Cristina Papayannidis; Giovanni Marconi; Eugenia Franchini; Elisa Zuffa; Maria Antonella Laginestra; Federica Zanotti; Annalisa Astolfi; Ilaria Iacobucci; Simona Bernardi; Marco Sazzini; Elisa Ficarra; Jesus Maria Hernandez; Peter Vandenberghe; Jan Cools; Lars Bullinger; Emanuela Ottaviani; Nicoletta Testoni; Michele Cavo; Torsten Haferlach; Gastone Castellani; Daniel Remondini; Giovanni Martinelli
Journal:  Cancer       Date:  2018-11-27       Impact factor: 6.860

View more
  1 in total

Review 1.  Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.

Authors:  Antonella Padella; Andrea Ghelli Luserna Di Rorà; Giovanni Marconi; Martina Ghetti; Giovanni Martinelli; Giorgia Simonetti
Journal:  J Hematol Oncol       Date:  2022-01-22       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.